China Universal Asset Management Company’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
China Universal Asset Management Company's HRMY Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Harmony Biosciences (HRMY) stake by 10% in Q2 2026, selling an estimated $33.1K and leaving 9,214 shares worth $335K. The position accounts for 0.02% of the portfolio, ranked #304.
China Universal Asset Management Company first reported a position in HRMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $437K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- China Universal Asset Management Company held 9,214 shares of Harmony Biosciences worth $335K as of Q2 2026.
- China Universal Asset Management Company sold 1,050 Harmony Biosciences shares in Q2 2026, an estimated $33.1K.
- Harmony Biosciences made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #304 holding.
- China Universal Asset Management Company first reported a position in Harmony Biosciences in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Harmony Biosciences position peaked at $437K in Q3 2024.
- 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.